Jan 25 (Reuters) - Cerenis Therapeutics Holding Sa :
* CASH POSITION AT END DEC 2017 EUR 16.3 MLN‍​ * ACQUIRES LYPRO BIOSCIENCES * INCLUSION OF THE FIRST PATIENTS IN THE TARGET STUDY * END OF PHASE III PATIENT RECRUITMENT IN TANGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 